Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: A randomized controlled trial

Obstetrics and Gynecology

Volumn 116, Issue 6, 2010, Pages 1455-1456

  Chelmow, David ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; LEVONORGESTREL; MEDROXYPROGESTERONE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

DRUG EFFICACY; DRUG INDICATION; FOOD AND DRUG ADMINISTRATION; INTRAUTERINE CONTRACEPTIVE DEVICE; LETTER; MENSTRUATION; MENSTRUATION DISORDER; PRIORITY JOURNAL;

CONTRACEPTIVES, ORAL, SYNTHETIC; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MEDROXYPROGESTERONE; MENORRHAGIA; PROGESTINS;

EID: 78650078192     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181ff731e     Document Type: Letter

References (5)

1. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding. Obstet Gynecol 2010;116:625-32.
2. National Collaborating Centre for Women's and Children's Health. Heavy menstrual bleeding. Commissioned by the National Institute for Health and Clinical Excellence. 2007. Available at: http://www.nice.org.uk/ nicemedia/live/11002/30401/30401.pdf. Retrieved September 7, 2010.
3. National Health Committee New Zealand Working Party. Guidelines for the management of heavy menstrual bleeding. 1998. Available at: http://www.nzgg.org. nz/guidelines/0032/HMB- fulltext.pdf. Retrieved September 7, 2010.
4. Lethaby A, Irvine GA, Cameron I. Cyclical progestogens for heavy menstrual bleeding. The Cochrane Database of Systematic Reviews 2008, Issue 1. No.: CD001016. DOI: 10.1002/ 14651858.CD001016.pub2.
5. Coulter A, Kelland J, Peto V, Rees MC. Treating menorrhagia in primary care: an overview of drug trials and a survey of prescribing practice. Int J Technol Assess Health Care 1995;11:456-71.